ClinicalTrials.Veeva

Menu

Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections (Her2F test)

A

Applied Spectral Imaging

Status

Completed

Conditions

Breast Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT01066507
ASI-Her2F

Details and patient eligibility

About

The purpose of the study is the identification of amplification level in human breast tissue. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of Her2 FISH stained tissue samples.

Enrollment

126 patients

Sex

Female

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Well stained breast tissue slides with bright Her2 signals

Exclusion criteria

  • Very old slides that were already bleached

Trial design

126 participants in 1 patient group

Breast cancer
Description:
Slides containing breast cancer paraffin embedded tissue sections.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems